HBV Vaccines
Lowering Dosage May Affect Long-Term Efficacy in Infants
Published in Hepatitis Weekly, October 28th, 1996
Researcher Johanna Goldfarb and colleagues compared the immunogenicity and safety of 5- and 10-(mu)g doses of the Engerix-B recombinant hepatitis B virus vaccine (SmithKline Beecham Pharmaceuticals, Conshohocken, PA) and found that 10-(mu)g doses appear to be safe in both groups and may offer longer protection.
Vaccination with hepatitis B vaccine is the most effective means of preventing HBV infection. The American Academy of Pediatrics and the Advisory...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-10-28)
More Articles from Hepatitis Weekly
- Disease Associations (HCV)
Hepatitis C May Be a Cause of Diabetes - Autoimmune Hepatitis
Recognition of Variant Forms Critical in Disease Treatment - Conference Coverage (ICAAC)
Six-Disease Vaccine Hailed as "Wave of Future" - Diagnostics (HCV)
Three Procedures Reliable in Genotyping Hepatitis C - Infection Control
Bacteria and Virus Passage Through Surgical Latex Gloves Confirmed - Occupational Risk
Workers Comp Protection Urged for Medical Students - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
